Childhood-onset striatonigral degeneration is a rare genetic disorder that robs children of the ability to walk and speak by ...
A recent study led by the UAB demonstrates the potential of gene therapy to restore motor capacity in an ultra-rare disease, ...
Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.
Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...
Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.
For cell and gene therapy, a consistent supply of quality starting material is vital that is maintained throughout the ...
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...
The death of a 16-year-old boy evokes a lengthy battle to realize the benefit of cutting-edge gene therapy while also ...
Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...
Shares of Sarepta Therapeutics have struggled for the past year due to concerns about the commercial potential of its gene ...
The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but ...
Inherited retinal degeneration (IRD) encompasses various disorders characterized by progressive loss of retinal photoreceptor cells, ultimately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results